Company intelligence / Profile preview

ACEL Pharma

Italy

Ownership: Private
Development stage: Other

Overview

ACEL Pharma is a manufacturing arm of the Candioli group, authorized by the Italian Ministry of Health to produce and package veterinary antiparasitic medicines for companion animals; products are already commercialized through Candioli’s veterinary portfolio.[1][4]

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

Candioli Pharma (in‑group manufacturing relationship for veterinary pharmaceuticals and nutritional products)[1][4]

Beyond the preview

Go deeper on ACEL Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACEL Pharma.

Explore the full profile